SpeechDx Featured in Alzheimer's & Dementia Journal for AI Speech Marker Research
SpeechDx was featured in a new paper published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, announced in a press release. The publication explores how artificial intelligence and digital speech-based markers are being used to advance early detection and monitoring of Alzheimer's disease.
The paper outlines how scalable digital biomarkers can help identify cognitive changes before clinical symptoms appear. It also highlights the SpeechDx initiative, which collects longitudinal speech data to support the creation of tools for predicting cognitive decline and enabling earlier intervention.
According to the release, SpeechDx aims to accelerate the development of digital markers that guide more personalized care and improve the ability to assess Alzheimer's risk in its earliest stages.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
BRAINIAC hub receives £20 million for AI dementia clinics
Alethios Adds Decentralized Health Research Data Suite
EDDA Technology Named to TIME HealthTech List for Second Year
Boehringer Ingelheim and Microsoft to Study Digital Patient Twins
Specialty1 Partners Invests in AI for Dental Practice Operations
Daily AI Brief: the AI news that matters, in your inbox.